{
  "abstract": "Background and Objectives: Epstein-Barr virus (EBV) infection is strongly implicated in multiple sclerosis (MS), yet the mechanisms linking EBV to disease pathogenesis remain unclear. EBV-specific T cells are hypothesized to contribute to MS through molecular mimicry. We aimed to investigate the relationship between EBV-specific T cells and MS relapses using longitudinal T-cell receptor (TCR) repertoire profiling.\n\nMethods: We analyzed TCR repertoires from sequential peripheral blood samples collected before and after relapses in 5 patients with MS. CD4+ and CD8+ T cells were sorted into naive, memory, and regulatory subsets. TCR antigen specificity was determined using exact matches to public databases and GLIPH2-based clustering, covering EBV, cytomegalovirus, influenza, Mycobacterium tuberculosis, and self-antigens. The results were compared with those from healthy controls.\n\nResults: At baseline, patients with MS showed a significant enrichment of EBV-specific TCRs within CD8+ T cells, comparable with patterns seen in other autoimmune diseases. After relapses, EBV-specific TCR frequencies markedly increased across all T-cell subsets. TCRs recognizing other viral antigens, including polyspecific TCRs with broad reactivity, displayed similar baseline enrichment and relapse-associated expansion patterns.\n\nDiscussion: Our findings indicate a temporal association between MS relapses, global immune activation, and EBV-specific T-cell expansions, which is consistent with a two-step model of MS relapse immunopathogenesis. An initial, unidentified trigger induces broad immune activation, promoting the expansion of antiviral T cells, including those specific to EBV. These EBV-specific and polyspecific T cells with heightened cross-reactivity may then contribute to MS relapses. Larger studies are needed to further define the role of T-cell dynamics in MS pathogenesis.",
  "abstract_shown": true,
  "affiliations": [
    "Sorbonne Université, INSERM, Immunoregulation-Immunopathology-Immunotherapy Lab (i3), Paris, France",
    "AP-HP, Clinical Investigation Center for Biotherapy and Immunology (CIC-BTi), Pitié-Salpêtrière Hospital, Paris, France ; and",
    "Department of Neurology, CIC Neurosciences, Sorbonne Université, Paris Brain Institute–ICM, Assistance Publique–Hôpitaux de Paris, INSERM, CNRS, Pitié-Salpêtrière Hospital, France ."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 13,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Leslie Adda",
      "orcid": "0000-0003-1395-6864"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Hélène Vantomme",
      "orcid": "0009-0008-8759-1208"
    },
    {
      "affs": [
        0
      ],
      "name": "Vanessa Mhanna"
    },
    {
      "affs": [
        0
      ],
      "name": "Paul Stys",
      "orcid": "0000-0003-4152-2887"
    },
    {
      "affs": [
        0
      ],
      "name": "Pierre Barennes"
    },
    {
      "affs": [
        0
      ],
      "name": "Charline Jouannet",
      "orcid": "0009-0008-0793-2296"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Nicolas Coatnoan",
      "orcid": "0000-0003-4129-0019"
    },
    {
      "affs": [
        0
      ],
      "name": "Vimala Diderot"
    },
    {
      "affs": [
        0
      ],
      "name": "Johanna Dubois",
      "orcid": "0009-0009-0440-150X"
    },
    {
      "affs": [
        2
      ],
      "name": "Celine Louapre",
      "orcid": "0000-0002-4987-1531"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Michelle Rosenzwajg",
      "orcid": "0000-0001-5312-6203"
    },
    {
      "affs": [
        0
      ],
      "name": "Encarnita Mariotti-Ferrandiz",
      "orcid": "0000-0002-8770-0186"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "David Klatzmann"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6j091n6d9jjh5.bib",
  "cited_by": 0,
  "doi": "10.1212/nxi.0000000000200645",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759265/",
  "id": "6j091n6d9jjh5",
  "issns": [
    "2332-7812"
  ],
  "landing_url": "https://doi.org/10.1212/nxi.0000000000200645",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "132"
    ],
    [
      "heading",
      "41"
    ],
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "2728|Multiple Sclerosis Research Studies"
    ]
  ],
  "openalex": "W7225827042",
  "pdf_url": "https://www.neurology.org/doi/pdf/10.1212/NXI.0000000000200645",
  "pmcid": "PMC13759265",
  "pmid": "43013798",
  "published": "2026-11-10",
  "publisher": "American Academy of Neurology",
  "ris": "https://research.draconitic.com/paper/6j091n6d9jjh5.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:56Z",
      "native_id": "PMC13759265",
      "source": "pmc",
      "url": "https://doi.org/10.1212/nxi.0000000000200645"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2728|Multiple Sclerosis Research Studies",
      "subfield": "neurology"
    }
  ],
  "title": "Multiple Sclerosis Relapses Are Associated With EBV-Specific T-Cell Expansion Amid Broad Immune Activation",
  "title_text": "Multiple Sclerosis Relapses Are Associated With EBV-Specific T-Cell Expansion Amid Broad Immune Activation",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:56Z",
  "url": "https://research.draconitic.com/paper/6j091n6d9jjh5",
  "venue": "Neurology® Neuroimmunology & Neuroinflammation",
  "versions": []
}